Your browser doesn't support javascript.
loading
Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection.
Kaushik, Ajeet; Yndart, Adriana; Atluri, Venkata; Tiwari, Sneham; Tomitaka, Asahi; Gupta, Purnima; Jayant, Rahul Dev; Alvarez-Carbonell, David; Khalili, Kamel; Nair, Madhavan.
Afiliación
  • Kaushik A; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Yndart A; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Atluri V; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Tiwari S; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Tomitaka A; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Gupta P; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Jayant RD; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Alvarez-Carbonell D; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA.
  • Khalili K; Department of Neuroscience, Lewis Katz School of Medicine, Temple University, Philadelphia, 19140, USA.
  • Nair M; Department of Immunology and Nano-Medicine, Center for Personalized Nanomedicine, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA. nairm@fiu.edu.
Sci Rep ; 9(1): 3928, 2019 03 08.
Article en En | MEDLINE | ID: mdl-30850620
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Barrera Hematoencefálica / Infecciones por VIH / VIH-1 / ARN Guía de Kinetoplastida Tipo de estudio: Evaluation_studies Aspecto: Implementation_research Límite: Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Barrera Hematoencefálica / Infecciones por VIH / VIH-1 / ARN Guía de Kinetoplastida Tipo de estudio: Evaluation_studies Aspecto: Implementation_research Límite: Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido